Children with Down's syndrome exhibit a staggering 150-fold increased risk of leukaemia, attributable to structural changes in genome configurations of fetal liver stem-cells.
The extra chromosome 21 in Down's syndrome alters how DNA is organized, exposing mutation-prone areas which are critical for leukaemia evolution.
By understanding the genomic modifications in liver stem-cells linked to Down's syndrome, researchers aim to provide insights that may eventually lower leukaemia risks.
The ongoing research on fetal liver stem-cells is pivotal for formulating strategies that could mitigate leukaemia risk in children diagnosed with Down's syndrome.
Collection
[
|
...
]